Rewriting the Hepatitis Playbook from B to C
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Infectious Diseases |
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Molecular Diagnostics |
Most Medicaid-enrolled children with autism or intellectual disability are not receiving recommended genetic testing.
Read MorePosted by Chris Wolski | Jun 18, 2025 | Cardiovascular |
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
Read MorePosted by Chris Wolski | Jun 17, 2025 | Breast |
Emerging liquid biopsy techniques enable sensitive, routine monitoring of ESR1 mutations in metastatic HR+ breast cancer.
Read MorePosted by Chris Wolski | Jun 12, 2025 | Digital Pathology |
Laboratory leaders see digital pathology and AI as essential for driving precision medicine and long-term transformation in the industry.
Read More